NewAmsterdam Pharma Company N.V. (NAMS)

SEC filing

NewAmsterdam Pharma Company N.V.

NAMS · CIK 1936258

4 · Sep 15, 2026 · Director, Chief Executive Officer Davidson Michael H. bought 10K shares at $22.65/share ($226.5K)

Director, Chief Executive Officer Davidson Michael H. bought 10K shares at $22.65/share ($226.5K)

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

nams-ex24_1.htm

nams-ex24_1.htmSEC.gov

Graphics and non-inline formats (not embedded below).